AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
EQT’s investment case still rests on its scale in Appalachian natural gas and its ability to convert that asset base into resilient cash flows. The latest earnings beat, helped by higher gas prices and volumes, supports the short term catalyst of better pricing, but the wastewater leak and lingering pipeline constraints underline that operational and regulatory risks remain the biggest near term overhang rather than a thesis-changing event.
Against that backdrop, EQT’s continued dividend at US$0.165 per share each quarter is the announcement that stands out most. For shareholders, a steady cash return policy can be a useful signal about balance sheet strength and management’s confidence in cash generation, but it also sits in tension with the capital and environmental demands highlighted by the recent operational issues.
Yet behind the improved quarter, investors should still be aware that ongoing environmental scrutiny around the wastewater leak could...
Read the full narrative on EQT (it's free!)
EQT's narrative projects $10.1 billion revenue and $3.4 billion earnings by 2029.
Uncover how EQT's forecasts yield a $70.04 fair value, a 28% upside to its current price.
Some of the lowest ranked analysts were already assuming roughly flat revenue at about US$9.4 billion and earnings of around US$2.8 billion, so if you worry about tighter regulation and oversupply, this quarter’s stronger pricing might only partially offset those concerns.
Explore 6 other fair value estimates on EQT - why the stock might be worth just $55.45!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com